Pembrolizumab as first therapy for elderly or comorbid patients with classical Hodgkin lymphoma: Results of the phase 2 PLIMATH trial
- Author(s)
- Dickinson, MJ; Berkahn, L; Trotman, J; Butler, J; Bressel, M; Neeson, P; Minson, AG;
- Journal Title
- British Journal of Haematology
- Publication Type
- Online publication before print
- Keywords
- Hodgkin lymphoma; checkpoint inhibitor; elderly; immunotherapy; pembrolizumab
- Department(s)
- Haematology; Laboratory Research; Biostatistics and Clinical Trials
- Publisher's Version
- https://doi.org/10.1111/bjh.70777
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2026-09-03 12:44:11
Last Modified: 2026-09-03 12:44:21